What is WISE SpA?
WISE SpA is a Milan- and Berlin-based medical device company focused on pioneering a new generation of implantable leads. Their proprietary technology enables the production of stretchable and flexible electrodes on medical-grade elastic polymers, addressing critical needs in neuromonitoring and neuromodulation. This innovation positions WISE SpA at the forefront of advanced medical technology, offering enhanced solutions for patient care and therapeutic interventions.
How much funding has WISE SpA raised?
WISE SpA has raised a total of $56.5M across 5 funding rounds:
Private Equity
$1.3M
Series A
$3.4M
Series B
$6.5M
Series C
$17.6M
Other Financing Round
$27.7M
Private Equity (2013): $1.3M with participation from b-to-v Partners and High-Tech Gru00fcnderfonds
Series A (2015): $3.4M led by High-Tech Gru00fcnderfonds and b-to-v Partners
Series B (2017): $6.5M supported by High-Tech Gründerfonds, Principia SGR, and btov Partners
Series C (2020): $17.6M featuring Indaco Ventures I Fund, High Tech Gründerfonds, Atlante Seed, EUREKA! Venture SGR, New Frontier, F3F, Principia SGR, Atlante Ventures, and CDP Venture Capital SGR
Other Financing Round (2024): $27.7M backed by European Investment Bank
Key Investors in WISE SpA
European Investment Bank
The European Investment Bank, established in 1958, is the European Union's nonprofit long-term lending and finance institution, often supporting strategic infrastructure and innovation projects.
Principia SGR
Principia SGR is a leading Italian venture capital firm with a dedicated focus on the healthcare sector, investing in start-ups and SMEs to foster growth and innovation.
btov Partners
btov Partners is a European venture firm specializing in early-stage investments, supporting entrepreneurs from seed to IPO with a strong network of angel investors and a focus on sectors like healthcare.
What's next for WISE SpA?
The substantial enterprise-level funding and recent strategic investment indicate a pivotal growth phase for WISE SpA. This capital is expected to accelerate product development, scale manufacturing capabilities, and expand market reach for their novel implantable leads. The company's trajectory suggests a strong focus on clinical validation and commercialization, aiming to solidify its position as a leader in the neuromodulation device sector.
See full WISE SpA company page
